Request Quote

From early method development to method validation using the MagMAX^™ System



Matthew Hankinson, Team Leader, Analytical Molecular Biology, Eden Biodesign

Matthew Hankinson attended the University of Sheffield in England and has worked in the biopharmaceutical industry for almost ten years in Analytical Development, where he specializes in molecular biology and cell-based methods. In his current position at Eden Bio design, he leads a research and development team specializing in developing and validating assays to support the range of biosimilars produced by Eden Biodesign.

Webinar Info

Lab productivity by reducing hands-on sample preparation time, costs and increasing throughput. Intuitive to operate and pre-loaded with protocols,SEQ automated sample preparation solutions offer reliable high recovery and consistent performance across a range of complex samples:

• Multi-assay, time-saving, cost-effective DNA extraction for Mycoplasma, MMV, Vesivirus, and residual host cell DNA quantitation
• Highly efficient, reproducible recovery of DNA from complex samples

In this session, you will learn how to maximize productivity, save time and increase reliability with the MagMAX^™ Express-96 Magnetic Particle Processor, our high-throughput 96-well format.

Register and watch the webinar now

Please fill out the following form before viewing this webinar. Fields marked with an asterisk are required.

• Name
  First Name *

  Last Name *

  Please enter your first and last name.

• E-mail Address *

  Please enter the e-mail address you would like to be contacted at.

• Company *

  Please enter the name of the company or institution you work at.

• City & Country
  City *

  Select Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia And Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic of the Cook Islands Costa Rica Côte D'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakstan Kenya Kiribati Korea, Democratic People's Republic of (North Korea) Korea, Republic of (South Korea) Kosovo Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States Of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent And The Grenadines Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard And Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, United States Wallis And Futuna Western Sahara Yemen Zambia Zimbabwe Country *

  Please enter your mailing address.

• Area of Bioprocessing *
  Upstream (i.e. cell line development, cell culture, cell therapy)Downstream (i.e. purification, chromatography, pre-packed process scale columns)

  Pharma Microbiology (i.e. QC micro)Biopharma Process Analytics (i.e. bacterial/fungal id, mycoplasma detection, micro virus detection)
• The contaminants you currently test for are (check all that apply): *
  MycoplasmaMouse minute virusVesivirus

  Other virusesNot presently testing for contaminants, but will have a need in the near future
• If you checked "Other Viruses" above, please list all:
• Which of the following impurities do you currently analyze? *
  Residual host cell DNA testingResidual Protein AHost Cell Proteins
• If you checked "Residual host cell DNA testing" above, please check all that apply
  CHOE.coliMDCKHuman

  PicchiaVeroOther
• If you checked "Other" above, please list all